Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
Holding PCRX?
Track your performance easily

Pacira Pharmaceuticals (PCRX) Financial Statements

350 Followers

Pacira Pharmaceuticals Financial Overview

Pacira Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $1.286; its P/E ratio is 13.08; Pacira Pharmaceuticals is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $0.70. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 178.02M$ 167.12M$ 181.24M$ 163.93M$ 169.47M
Gross Profit$ 133.76M$ 119.70M$ 133.55M$ 124.18M$ 104.65M
EBIT$ 40.47M$ 18.86M-$ 23.54M$ 45.57M
EBITDA$ 60.12M$ 37.99M-$ 42.68M$ 65.34M
Net Income Common Stockholders$ 18.89M$ 8.98M$ 24.87M$ 17.57M$ 25.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 404.23M$ 325.89M$ 278.58M$ 235.19M$ 220.77M
Total Assets$ 1.65B$ 1.58B$ 1.57B$ 1.53B$ 1.54B
Total Debt$ 648.60M$ 581.78M$ 586.04M$ 590.30M$ 620.71M
Net Debt$ 244.37M$ 255.89M$ 307.46M$ 355.11M$ 399.95M
Total Liabilities$ 767.54M$ 691.16M$ 704.26M$ 702.91M$ 734.41M
Stockholders Equity$ 879.28M$ 892.16M$ 870.13M$ 831.55M$ 807.98M
Cash Flow-
Free Cash Flow$ 51.65M$ 46.27M-$ 41.04M$ 51.71M
Operating Cash Flow$ 53.24M$ 49.10M$ 47.58M$ 44.44M$ 55.12M
Investing Cash Flow$ -15.21M$ -15.53M$ 8.37M$ -4.34M$ -4.29M
Financing Cash Flow$ 24.98M$ -2.82M$ -1.78M$ -27.79M$ 440.00K
Currency in USD

Pacira Pharmaceuticals Earnings and Revenue History

Pacira Pharmaceuticals Debt to Assets

Pacira Pharmaceuticals Cash Flow

Pacira Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis